# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Stargardt Disease
- **MONDO ID:**  (if available)
- **Category:** Mendelian

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Stargardt Disease**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-02-27T02:18:28.268888

1. fujinami2024stargardtmaculardystrophy pages 2-2
2. ghenciu2024emergingtherapeuticapproaches pages 4-5
3. ng2024impairedcathepsind pages 1-3
4. ng2024impairedcathepsind pages 12-13
5. akula2024retinoicacidrelated pages 7-8
6. xie2024assayingtherole pages 36-40
7. watson2023unravellingstargardtdisease pages 35-39
8. fujinami2024stargardtmaculardystrophy pages 4-5
9. gomezbenlloch2024opticalcoherencetomography pages 2-4
10. wang2023updatesonemerging pages 2-4
11. wang2023updatesonemerging pages 6-7
12. wang2023updatesonemerging pages 4-5
13. fujinami2024stargardtmaculardystrophy pages 6-7
14. fujinami2024stargardtmaculardystrophy pages 7-7
15. fujinami2024stargardtmaculardystrophy pages 6-6
16. ghenciu2024emergingtherapeuticapproaches pages 2-4
17. wang2023updatesonemerging pages 1-2
18. xie2024assayingtherole pages 5-11
19. yu2025mechanismsandfunctions pages 10-11
20. https://doi.org/10.1096/fj.202400210RR
21. https://doi.org/10.1136/bjo-2022-323071
22. https://doi.org/10.3390/jcm12196229
23. https://doi.org/10.3390/ijms25168859
24. https://doi.org/10.1038/s41434-024-00455-z
25. https://doi.org/10.3390/diagnostics14090878
26. https://doi.org/10.3390/diagnostics14090878,
27. https://doi.org/10.3390/jcm12196229,
28. https://doi.org/10.1096/fj.202400210rr,
29. https://doi.org/10.1136/bjo-2022-323071,
30. https://doi.org/10.3390/ijms25168859,
31. https://doi.org/10.1038/s41434-024-00455-z,
32. https://doi.org/10.3390/biom15121676,